Pyrazine derivatives, Methods of use, and methods for preparing same
a technology of pyrazine and derivatives, which is applied in the field of methods for producing pyrazine derivatives, can solve the problems of undesirable for a number of medical uses, markers and methods suffer from drawbacks, etc., and achieve the effect of rapid renal clearan
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Benefits of technology
Problems solved by technology
Method used
Image
Examples
example 1
Protocol for Assessing Renal Function
[0143]An example of an in vivo renal monitoring assembly 10 is shown in FIG. 1 and includes a light source 12 and a data processing system 14. The light source 12 generally includes or is interconnected with an appropriate device for exposing at least a portion of a patient's body to light therefrom. Examples of appropriate devices that may be interconnected with or be a part of the light source 12 include, but are not limited to, catheters, endoscopes, fiber optics, ear clips, hand bands, head bands, forehead sensors, surface coils, and finger probes. Indeed, any of a number of devices capable of emitting visible and / or near infrared light of the light source may be employed in the renal monitoring assembly 10.
[0144]Still referring to FIG. 1, the data processing system 14 of the renal monitoring assembly 10 may be any appropriate system capable of detecting spectral energy and processing data indicative of the spectral energy. For instance, the ...
example 2
Synthesis of Representative Pyrazine PEG Analogues
[0148]Unless otherwise noted, all reagents in this Example were used as supplied. Organic extracts were dried over anhydrous Na2SO4 and filtered using a fluted filter paper (P8). Solvents were removed on a rotary evaporator under reduced pressure. RP-LC / MS (ESI, positive ion mode) analyses were carried out on a Waters Micromass ZQ system equipped with a PDA detector using either a BDS Hypersil C18 3 μm (50 mm×4.6 mm) or a ThermoElectron Hypersil Gold C18 3 μm (4.6 mm×50 mm) column. Compounds were injected using a gradient condition (5 to 50-95% B / 6 min) with a flow rate of 1 mL / min (mobile phase A: 0.05% TFA in H2O; mobile phase B: 0.05% TFA in CH3CN). Chemical shifts are expressed in parts per million (δ) relative to TMS (δ=0) as an internal standard and coupling constants (J) are reported in Hz.
A. Diethyl 3,6-bis(benzylamino)pyrazine-2,5-dicarboxylate (7)
[0149]
[0150]To a well-stirred red suspension of diethyl 3,6-diaminopyrazine-2,...
PUM
| Property | Measurement | Unit |
|---|---|---|
| temperature | aaaaa | aaaaa |
| temperature | aaaaa | aaaaa |
| wavelength | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More 


